Z
Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079
Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079
Price:
16.69
CNY
0.91%
Market Closed
Market Cap:
¥3.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Z
|
Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079
|
CN |
|
N
|
Ningbo Orient Wires & Cables Co Ltd
SSE:603606
|
CN |
|
T
|
Tianjin Capital Environmental Protection Group Co Ltd
SSE:600874
|
CN |
|
Global Payments Inc
NYSE:GPN
|
US |
Income Statement
Earnings Waterfall
Zhejiang Shengda Bio-Pharm Co Ltd
Zhejiang Shengda Bio-Pharm Co Ltd
Income Statement
Zhejiang Shengda Bio-Pharm Co Ltd
Zhejiang Shengda Bio-Pharm Co Ltd
Currency: CNY
| Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
5
|
0
|
0
|
2
|
6
|
6
|
8
|
9
|
11
|
12
|
0
|
8
|
5
|
3
|
5
|
4
|
6
|
6
|
5
|
6
|
5
|
3
|
2
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
0
|
|
| Revenue |
455
N/A
|
471
+3%
|
509
+8%
|
510
+0%
|
472
-7%
|
494
+5%
|
493
0%
|
496
+1%
|
529
+7%
|
512
-3%
|
519
+1%
|
594
+15%
|
719
+21%
|
812
+13%
|
867
+7%
|
863
-1%
|
807
-6%
|
780
-3%
|
790
+1%
|
783
-1%
|
750
-4%
|
746
-1%
|
738
-1%
|
722
-2%
|
751
+4%
|
746
-1%
|
727
-3%
|
743
+2%
|
749
+1%
|
792
+6%
|
827
+4%
|
846
+2%
|
844
0%
|
840
0%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(306)
|
(315)
|
(316)
|
(308)
|
(288)
|
(313)
|
(333)
|
(353)
|
(372)
|
(353)
|
(343)
|
(343)
|
(351)
|
(375)
|
(407)
|
(453)
|
(499)
|
(531)
|
(571)
|
(569)
|
(554)
|
(572)
|
(627)
|
(618)
|
(657)
|
(654)
|
(653)
|
(631)
|
(629)
|
(658)
|
(664)
|
(660)
|
(645)
|
(637)
|
|
| Gross Profit |
149
N/A
|
155
+4%
|
192
+24%
|
202
+5%
|
185
-8%
|
181
-2%
|
160
-11%
|
143
-11%
|
158
+10%
|
160
+1%
|
177
+11%
|
252
+42%
|
368
+46%
|
437
+19%
|
460
+5%
|
410
-11%
|
308
-25%
|
249
-19%
|
219
-12%
|
214
-2%
|
196
-8%
|
174
-11%
|
111
-36%
|
104
-6%
|
94
-10%
|
93
-2%
|
74
-20%
|
112
+51%
|
120
+8%
|
134
+11%
|
164
+22%
|
186
+14%
|
199
+7%
|
203
+2%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||
| Operating Expenses |
(94)
|
(84)
|
(91)
|
(82)
|
(85)
|
(93)
|
(112)
|
(111)
|
(116)
|
(119)
|
(123)
|
(145)
|
(175)
|
(189)
|
(192)
|
(191)
|
(172)
|
(165)
|
(151)
|
(144)
|
(147)
|
(143)
|
(108)
|
(120)
|
(121)
|
(112)
|
(120)
|
(168)
|
(161)
|
(167)
|
(128)
|
(128)
|
(124)
|
(122)
|
|
| Selling, General & Administrative |
(94)
|
(85)
|
(66)
|
(97)
|
(101)
|
(103)
|
(79)
|
(92)
|
(91)
|
(92)
|
(87)
|
(109)
|
(133)
|
(146)
|
(144)
|
(144)
|
(124)
|
(115)
|
(96)
|
(109)
|
(112)
|
(111)
|
(69)
|
(76)
|
(72)
|
(64)
|
(71)
|
(80)
|
(78)
|
(82)
|
(82)
|
(81)
|
(79)
|
(75)
|
|
| Research & Development |
0
|
0
|
(23)
|
0
|
0
|
(5)
|
(20)
|
(16)
|
(21)
|
(25)
|
(27)
|
(28)
|
(34)
|
(36)
|
(33)
|
(39)
|
(39)
|
(37)
|
(37)
|
(39)
|
(40)
|
(40)
|
(36)
|
(39)
|
(39)
|
(39)
|
(40)
|
(42)
|
(41)
|
(42)
|
(41)
|
(46)
|
(48)
|
(50)
|
|
| Depreciation & Amortization |
0
|
0
|
(13)
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
(18)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(26)
|
0
|
0
|
0
|
(16)
|
0
|
0
|
0
|
(18)
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
11
|
13
|
15
|
14
|
3
|
(2)
|
(3)
|
(2)
|
9
|
(8)
|
(8)
|
(7)
|
7
|
(8)
|
(9)
|
(13)
|
7
|
4
|
5
|
8
|
14
|
(5)
|
(10)
|
(8)
|
9
|
(47)
|
(42)
|
(43)
|
9
|
(1)
|
3
|
4
|
|
| Operating Income |
55
N/A
|
71
+30%
|
101
+41%
|
120
+19%
|
100
-17%
|
88
-12%
|
48
-45%
|
32
-33%
|
42
+29%
|
41
-3%
|
54
+33%
|
106
+96%
|
192
+81%
|
248
+29%
|
268
+8%
|
219
-19%
|
137
-38%
|
84
-38%
|
68
-19%
|
70
+3%
|
49
-31%
|
31
-36%
|
3
-89%
|
(16)
N/A
|
(27)
-70%
|
(19)
+28%
|
(46)
-141%
|
(56)
-21%
|
(41)
+27%
|
(33)
+20%
|
36
N/A
|
58
+62%
|
75
+29%
|
82
+9%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(0)
|
(5)
|
(15)
|
(21)
|
(9)
|
1
|
5
|
8
|
3
|
1
|
(4)
|
1
|
(1)
|
(13)
|
(21)
|
(20)
|
(17)
|
(2)
|
13
|
10
|
29
|
35
|
33
|
34
|
18
|
8
|
11
|
12
|
12
|
9
|
11
|
9
|
5
|
9
|
|
| Non-Reccuring Items |
1
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
11
|
11
|
0
|
(0)
|
(10)
|
(11)
|
0
|
0
|
1
|
(0)
|
(0)
|
(2)
|
(4)
|
(4)
|
(23)
|
(23)
|
(21)
|
(22)
|
0
|
(1)
|
(1)
|
1
|
1
|
(0)
|
(1)
|
(1)
|
2
|
1
|
8
|
8
|
11
|
3
|
(4)
|
(5)
|
|
| Pre-Tax Income |
66
N/A
|
76
+16%
|
86
+13%
|
99
+15%
|
81
-18%
|
78
-4%
|
52
-33%
|
41
-23%
|
45
+11%
|
40
-11%
|
49
+22%
|
105
+113%
|
187
+79%
|
231
+24%
|
224
-3%
|
176
-21%
|
99
-44%
|
60
-39%
|
80
+33%
|
79
-2%
|
76
-4%
|
67
-12%
|
37
-45%
|
18
-50%
|
(9)
N/A
|
(12)
-32%
|
(45)
-265%
|
(43)
+4%
|
(21)
+51%
|
(15)
+28%
|
49
N/A
|
69
+41%
|
75
+9%
|
86
+14%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||
| Tax Provision |
(11)
|
(12)
|
(13)
|
(15)
|
(13)
|
(12)
|
(10)
|
(8)
|
(8)
|
(8)
|
(11)
|
(21)
|
(32)
|
(38)
|
(34)
|
(24)
|
(13)
|
(7)
|
(8)
|
(9)
|
(10)
|
(10)
|
(6)
|
(5)
|
(5)
|
(5)
|
(9)
|
(9)
|
(8)
|
(9)
|
(12)
|
(14)
|
(17)
|
(17)
|
|
| Income from Continuing Operations |
55
|
64
|
73
|
84
|
68
|
67
|
43
|
33
|
38
|
32
|
38
|
84
|
155
|
194
|
190
|
152
|
86
|
53
|
72
|
70
|
65
|
57
|
30
|
13
|
(15)
|
(17)
|
(54)
|
(52)
|
(29)
|
(24)
|
37
|
55
|
58
|
69
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
6
|
9
|
12
|
9
|
9
|
8
|
7
|
8
|
8
|
4
|
3
|
2
|
1
|
1
|
1
|
(0)
|
(1)
|
0
|
(2)
|
(3)
|
(5)
|
(8)
|
(8)
|
(8)
|
(7)
|
|
| Net Income (Common) |
55
N/A
|
64
+18%
|
73
+13%
|
84
+15%
|
68
-18%
|
67
-2%
|
45
-33%
|
35
-22%
|
41
+19%
|
38
-9%
|
47
+25%
|
95
+103%
|
165
+72%
|
203
+23%
|
197
-3%
|
158
-20%
|
94
-41%
|
61
-35%
|
76
+24%
|
73
-3%
|
68
-7%
|
58
-15%
|
31
-46%
|
14
-55%
|
(15)
N/A
|
(18)
-23%
|
(54)
-197%
|
(54)
+1%
|
(31)
+42%
|
(29)
+8%
|
29
N/A
|
47
+61%
|
51
+7%
|
61
+20%
|
|
| EPS (Diluted) |
0.46
N/A
|
0.54
+17%
|
0.56
+4%
|
0.53
-5%
|
0.45
-15%
|
0.41
-9%
|
0.28
-32%
|
0.21
-25%
|
0.26
+24%
|
0.24
-8%
|
0.3
+25%
|
0.53
+77%
|
0.96
+81%
|
1.11
+16%
|
1.17
+5%
|
0.91
-22%
|
0.53
-42%
|
0.36
-32%
|
0.44
+22%
|
0.43
-2%
|
0.39
-9%
|
0.33
-15%
|
0.18
-45%
|
0.08
-56%
|
-0.09
N/A
|
-0.11
-22%
|
-0.32
-191%
|
-0.33
-3%
|
-0.2
+39%
|
-0.18
+10%
|
0.17
N/A
|
0.28
+65%
|
0.3
+7%
|
0.32
+7%
|
|
Switch to:
Switch to:
See Also
Discover More
